$514 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 123 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THC | TENET HEALTHCARE | $6,028,935 | -19.0% | 91,500 | 0.0% | 1.17% | -5.5% | |
| ABBV | ABBVIE INC | $5,858,058 | +10.6% | 39,300 | 0.0% | 1.14% | +29.2% | |
| MRK | MERCK & CO INC | $5,662,250 | -10.8% | 55,000 | 0.0% | 1.10% | +4.3% | |
| BSX | BOSTON SCIENTIFIC | $5,225,933 | -2.4% | 98,976 | 0.0% | 1.02% | +14.0% | |
| PFE | PFIZER INC | $5,220,958 | -9.6% | 157,400 | 0.0% | 1.02% | +5.6% | |
| GKOS | GLAUKOS CORP | $5,192,250 | +5.7% | 69,000 | 0.0% | 1.01% | +23.4% | |
| TMO | THERMO FISHER SCI | $3,626,708 | -3.0% | 7,165 | 0.0% | 0.71% | +13.3% | |
| MDT | MEDTRONIC PLC | $3,138,396 | -11.1% | 40,051 | 0.0% | 0.61% | +3.9% | |
| DHR | DANAHER CORP | $2,722,898 | +3.4% | 10,975 | 0.0% | 0.53% | +20.7% | |
| EFFECTOR THERAPEUTCS | $1,429,348 | -27.7% | 2,382,644 | 0.0% | 0.28% | -15.8% | ||
| GBIO | GENERATION BIO CO | $1,352,045 | -31.1% | 356,740 | 0.0% | 0.26% | -19.6% | |
| RALLYBIO CORP | $1,266,985 | -40.5% | 375,960 | 0.0% | 0.25% | -30.4% | ||
| FUSN | FUSION PHARMACEUTI | $148,972 | -44.3% | 57,297 | 0.0% | 0.03% | -35.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.